勘误：埃克替尼治疗肺腺癌脑转移患者的疗效和安全性[更正]
Erratum: Efficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma [Corrigendum].
出版信息
Onco Targets Ther. 2017 Mar 21;10:1709. doi: 10.2147/OTT.S135456. eCollection 2017.
Abstract
[This corrects the article on p. 2911 in vol. 9, PMID: 27274284.].
摘要
[本文纠正了第9卷第2911页的文章， PMID: 27274284。]
相似文献
1
Erratum: Efficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma [Corrigendum].勘误：埃克替尼治疗肺腺癌脑转移患者的疗效和安全性[更正]
Onco Targets Ther. 2017 Mar 21;10:1709. doi: 10.2147/OTT.S135456. eCollection 2017.
2
Corrigendum.勘误
Paediatr Child Health. 2015 Nov-Dec;20(8):466-7. doi: 10.1093/pch/20.8.466.
3
Efficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma.埃克替尼治疗肺腺癌脑转移患者的疗效和安全性。
Onco Targets Ther. 2016 May 17;9:2911-7. doi: 10.2147/OTT.S102472. eCollection 2016.
4
Erratum: Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy [Corrigendum].勘误：艾日布林治疗转移性乳腺癌：安全性和疗效最新进展[勘误]
Int J Womens Health. 2015 Apr 16;7:403. doi: 10.2147/IJWH.S85889. eCollection 2015.
5
Erratum: Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: a subgroup analysis from the SHINE study [Corrigendum].勘误：茚达特罗/格隆溴铵在日本慢性阻塞性肺疾病患者中的疗效和安全性：SHINE研究的亚组分析[勘误]
Int J Chron Obstruct Pulmon Dis. 2017 Jan 10;12:231. doi: 10.2147/COPD.S127610. eCollection 2017.
6
Erratum: The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum].勘误：亚氯酸钠保存的0.1%酒石酸溴莫尼定对日本正在接受治疗的正常眼压性青光眼患者的疗效和安全性[勘误]
Clin Ophthalmol. 2015 Mar 9;9:453. doi: 10.2147/OPTH.S81448. eCollection 2015.
7
Erratum: The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum].勘误：亚氯酸钠保存的0.1%酒石酸溴莫尼定对日本正在接受治疗的正常眼压性青光眼患者的疗效和安全性[勘误]
Clin Ophthalmol. 2015 Jul 22;9:1365. doi: 10.2147/OPTH.S91388. eCollection 2015.
8
Icotinib as initial treatment in lung adenocarcinoma patients with brain metastases.厄洛替尼治疗伴脑转移的肺腺癌患者的初步研究
Thorac Cancer. 2016 Jul;7(4):437-41. doi: 10.1111/1759-7714.12351. Epub 2016 Apr 5.
9
Erratum: Assessment of safety and efficacy of lamotrigine over the course of 1-year observation in Japanese patients with bipolar disorder: post-marketing surveillance study report [Corrigendum].勘误：拉莫三嗪在日本双相情感障碍患者1年观察期内的安全性和有效性评估：上市后监测研究报告[更正]
Neuropsychiatr Dis Treat. 2017 Aug 18;13:2219. doi: 10.2147/NDT.S148233. eCollection 2017.
10
Icotinib versus whole-brain irradiation in patients with EGFR-mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial.厄洛替尼对比全脑放疗用于表皮生长因子受体突变型非小细胞肺癌伴多发脑转移患者（BRAIN）：一项多中心、三期、开放标签、平行、随机对照临床试验。
Lancet Respir Med. 2017 Sep;5(9):707-716. doi: 10.1016/S2213-2600(17)30262-X. Epub 2017 Jul 19.
Zotero 插件